{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Placebo+for+Bococizumab+%28PF-04950615%3BRN316%29", "query": { "intervention": "Placebo for Bococizumab (PF-04950615;RN316)" }, "page_size": 10 }, "pagination": { "page": 1, "page_size": 10, "total_count": 7, "total_pages": 1, "next_page_url": null, "previous_page_url": null }, "source": "remote", "last_synced_at": "2026-10-11T05:27:57.741Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT02135029", "title": "Randomized Clinical Trial of Bococizumab (PF-04950615; RN316) in Subjects Who Are Intolerant to Statins", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Hyperlipidemia" ], "interventions": [ { "name": "Bococizumab (PF-04950615;RN316)", "type": "DRUG" }, { "name": "Atorvastatin", "type": "DRUG" }, { "name": "Placebo for Bococizumab (PF-04950615;RN316)", "type": "OTHER" }, { "name": "Placebo for atorvastatin", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "Pfizer", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 184, "start_date": "2014-06", "completion_date": "2015-11", "has_results": true, "last_update_posted_date": "2017-12-14", "last_synced_at": "2026-10-11T05:27:57.741Z", "location_count": 31, "location_summary": "Denver, Colorado • Bridgeport, Connecticut • Lakeland, Florida + 24 more", "locations": [ { "city": "Denver", "state": "Colorado" }, { "city": "Bridgeport", "state": "Connecticut" }, { "city": "Lakeland", "state": "Florida" }, { "city": "Miami", "state": "Florida" }, { "city": "Ponte Vedra", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT02135029" }, { "nct_id": "NCT01592240", "title": "Monthly And Twice Monthly Subcutaneous Dosing Of PF-04950615 (RN316) In Hypercholesterolemic Subjects On A Statin", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Hypercholesterolemia" ], "interventions": [ { "name": "PBO", "type": "DRUG" }, { "name": "200mg PF-04950615 (RN316)", "type": "DRUG" }, { "name": "300mg PF-04950615 (RN316)", "type": "DRUG" }, { "name": "PF-04950615", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Pfizer", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 354, "start_date": "2012-07", "completion_date": "2013-05", "has_results": true, "last_update_posted_date": "2017-12-05", "last_synced_at": "2026-10-11T05:27:57.741Z", "location_count": 74, "location_summary": "Birmingham, Alabama • Huntsville, Alabama • Tucson, Arizona + 59 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Huntsville", "state": "Alabama" }, { "city": "Huntsville", "state": "Alabama" }, { "city": "Tucson", "state": "Arizona" }, { "city": "Little Rock", "state": "Arkansas" } ], "official_url": "https://clinicaltrials.gov/study/NCT01592240" }, { "nct_id": "NCT01968980", "title": "A 52 Week Study To Assess The Use Of Bococizumab (PF-04950615; RN316) In Subjects With Heterozygous Familial Hypercholesterolemia", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Heterozygous Familial Hypercholesterolemia" ], "interventions": [ { "name": "Bococizumab (PF-04950615;RN316)", "type": "DRUG" }, { "name": "Placebo", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "Pfizer", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 370, "start_date": "2013-10-23", "completion_date": "2016-04-15", "has_results": true, "last_update_posted_date": "2017-06-26", "last_synced_at": "2026-10-11T05:27:57.741Z", "location_count": 22, "location_summary": "Los Angeles, California • Hartford, Connecticut • Hialeah, Florida + 13 more", "locations": [ { "city": "Los Angeles", "state": "California" }, { "city": "Hartford", "state": "Connecticut" }, { "city": "Hialeah", "state": "Florida" }, { "city": "Miami", "state": "Florida" }, { "city": "Miami", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT01968980" }, { "nct_id": "NCT01968967", "title": "Randomized Clinical Trial of Bococizumab (PF-04950615; RN316) in Subjects With Hyperlipidemia or Mixed Dyslipidemia at Risk of Cardiovascular Events", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Hyperlipidemia" ], "interventions": [ { "name": "Bococizumab (PF-04950615; RN316)", "type": "DRUG" }, { "name": "Placebo", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "Pfizer", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 2139, "start_date": "2013-10-29", "completion_date": "2017-07-10", "has_results": true, "last_update_posted_date": "2018-07-31", "last_synced_at": "2026-10-11T05:27:57.741Z", "location_count": 155, "location_summary": "Athens, Alabama • Birmingham, Alabama • Huntsville, Alabama + 115 more", "locations": [ { "city": "Athens", "state": "Alabama" }, { "city": "Athens", "state": "Alabama" }, { "city": "Birmingham", "state": "Alabama" }, { "city": "Birmingham", "state": "Alabama" }, { "city": "Birmingham", "state": "Alabama" } ], "official_url": "https://clinicaltrials.gov/study/NCT01968967" }, { "nct_id": "NCT01968954", "title": "Randomized Clinical Trial Of Bococizumab (PF-04950615; RN316) In Subjects With Hyperlipidemia Or Mixed Dyslipidemia At Risk Of Cardiovascular Events", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Hyperlipidemia" ], "interventions": [ { "name": "Bococizumab (PF-04950615;RN316)", "type": "DRUG" }, { "name": "Placebo", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "Pfizer", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 711, "start_date": "2013-10", "completion_date": "2016-04", "has_results": true, "last_update_posted_date": "2017-05-17", "last_synced_at": "2026-10-11T05:27:57.741Z", "location_count": 58, "location_summary": "Birmingham, Alabama • Tucson, Arizona • Encinitas, California + 45 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Birmingham", "state": "Alabama" }, { "city": "Tucson", "state": "Arizona" }, { "city": "Tucson", "state": "Arizona" }, { "city": "Encinitas", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT01968954" }, { "nct_id": "NCT02100514", "title": "Randomized Clinical Trial of Bococizumab (PF-04950615; RN316) in Subjects With Primary Hyperlipidemia or Mixed Dyslipidemia At Risk Of Cardiovascular Events", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Hyperlipidemia" ], "interventions": [ { "name": "Bococizumab (PF-04950615; RN316)", "type": "DRUG" }, { "name": "Placebo", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "Pfizer", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 746, "start_date": "2014-10-28", "completion_date": "2017-07-10", "has_results": true, "last_update_posted_date": "2018-07-31", "last_synced_at": "2026-10-11T05:27:57.741Z", "location_count": 108, "location_summary": "Alexander City, Alabama • Auburn, Alabama • Phoenix, Arizona + 72 more", "locations": [ { "city": "Alexander City", "state": "Alabama" }, { "city": "Auburn", "state": "Alabama" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Tucson", "state": "Arizona" } ], "official_url": "https://clinicaltrials.gov/study/NCT02100514" }, { "nct_id": "NCT00991159", "title": "A Study To Access The Safety And Tolerability Of RN316 (PF-04950615) When Administered To Healthy Adult Subjects", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Healthy" ], "interventions": [ { "name": "RN316", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Pfizer", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "70 Years", "sex": "ALL", "summary": "18 Years to 70 Years" }, "enrollment_count": 48, "start_date": "2009-11", "completion_date": "2010-05", "has_results": false, "last_update_posted_date": "2012-07-04", "last_synced_at": "2026-10-11T05:27:57.741Z", "location_count": 2, "location_summary": "Phoenix, Arizona • Miami Gardens, Florida", "locations": [ { "city": "Phoenix", "state": "Arizona" }, { "city": "Miami Gardens", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT00991159" } ] }